These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2391515)

  • 1. Changes in signal transduction in Alzheimer's disease.
    Shimohama S; Ninomiya H; Saitoh T; Terry RD; Fukunaga R; Taniguchi T; Fujiwara M; Kimura J; Kameyama M
    J Neural Transm Suppl; 1990; 30():69-78. PubMed ID: 2391515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential involvement of protein kinase C isozymes in Alzheimer's disease.
    Masliah E; Cole G; Shimohama S; Hansen L; DeTeresa R; Terry RD; Saitoh T
    J Neurosci; 1990 Jul; 10(7):2113-24. PubMed ID: 2376771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
    Clark EA; Leach KL; Trojanowski JQ; Lee VM
    Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]N-[1-(2-thienyl)cyclohexyl]-3,4-piperidine ([3H]TCP) binding in human frontal cortex: decreases in Alzheimer-type dementia.
    Ninomiya H; Fukunaga R; Taniguchi T; Fujiwara M; Shimohama S; Kameyama M
    J Neurochem; 1990 Feb; 54(2):526-32. PubMed ID: 1967631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional changes in [3H]D-aspartate and [3H]TCP binding sites in Alzheimer's disease brains.
    Simpson MD; Royston MC; Deakin JF; Cross AJ; Mann DM; Slater P
    Brain Res; 1988 Oct; 462(1):76-82. PubMed ID: 2846124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of protein kinase C mRNA levels in Alzheimer's disease brains.
    Chachin M; Shimohama S; Kunugi YU; Taniguchi T
    Jpn J Pharmacol; 1996 Jun; 71(2):175-7. PubMed ID: 8835644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients.
    Govoni S; Bergamaschi S; Racchi M; Battaini F; Binetti G; Bianchetti A; Trabucchi M
    Neurology; 1993 Dec; 43(12):2581-6. PubMed ID: 8255461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C alteration is an early biochemical marker in Alzheimer's disease.
    Masliah E; Cole GM; Hansen LA; Mallory M; Albright T; Terry RD; Saitoh T
    J Neurosci; 1991 Sep; 11(9):2759-67. PubMed ID: 1880547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain.
    Wang HY; Pisano MR; Friedman E
    Neurobiol Aging; 1994; 15(3):293-8. PubMed ID: 7936052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease.
    Shimohama S; Narita M; Matsushima H; Kimura J; Kameyama M; Hagiwara M; Hidaka H; Taniguchi T
    Neurology; 1993 Jul; 43(7):1407-13. PubMed ID: 8327146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperactivation of signal transduction systems in Alzheimer's disease.
    Saitoh T; Horsburgh K; Masliah E
    Ann N Y Acad Sci; 1993 Sep; 695():34-41. PubMed ID: 8239309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and phosphorylation of protein kinase C isoforms in Abeta(1-42) activated T lymphocytes from Alzheimers disease.
    Ciccocioppo F; Lanuti P; Marchisio M; Gambi F; Santavenere E; Pierdomenico L; Bascelli A; Velluto L; Gambi D; Miscia S
    Int J Immunopathol Pharmacol; 2008; 21(1):23-33. PubMed ID: 18336728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients.
    Battaini F; Pascale A; Lucchi L; Pasinetti GM; Govoni S
    Exp Neurol; 1999 Oct; 159(2):559-64. PubMed ID: 10506528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in protein kinase C isozymes in the rat hippocampal formation following hippocampal lesion.
    Shimohama S; Saitoh T; Gage FH
    Hippocampus; 1993 Jan; 3(1):43-55. PubMed ID: 8364682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease.
    Matsushima H; Shimohama S; Chachin M; Taniguchi T; Kimura J
    J Neurochem; 1996 Jul; 67(1):317-23. PubMed ID: 8667008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex.
    Carlson MD; Penney JB; Young AB
    Neurobiol Aging; 1993; 14(4):343-52. PubMed ID: 7690114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology.
    Kurumatani T; Fastbom J; Bonkale WL; Bogdanovic N; Winblad B; Ohm TG; Cowburn RF
    Brain Res; 1998 Jun; 796(1-2):209-21. PubMed ID: 9689471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C activity and protein levels in Alzheimer's disease.
    Lanius RA; Wagey R; Sahl B; Beattie BL; Feldman H; Pelech SL; Krieger C
    Brain Res; 1997 Aug; 764(1-2):75-80. PubMed ID: 9295195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral microvessels in Alzheimer's have reduced protein kinase C activity.
    Grammas P; Moore P; Botchlet T; Hanson-Painton O; Cooper DR; Ball MJ; Roher A
    Neurobiol Aging; 1995; 16(4):563-9. PubMed ID: 8544906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory amino acid receptors in the human cerebral cortex: a quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine, L-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites.
    Jansen KL; Faull RL; Dragunow M
    Neuroscience; 1989; 32(3):587-607. PubMed ID: 2557558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.